CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-07 | DeGolyer Donald W Director | Sale 10b5-1 | −17,800 | $7.09 | $126K | 111,921 |
| 2026-10-01 | Williams Paul Anthony SVP, Products Business | Sale 10b5-1 | −3,000 | $6.53 | $20K | 156,098 |
| 2026-07-01 | Williams Paul Anthony SVP, Products Business | Sale 10b5-1 | −3,000 | $8.40 | $25K | 159,098 |
| 2026-06-08 | Hartzel William SVP, Bioservices | Shares withheld for taxes | −1,741 | $8.00 | $14K | 185,558 |
| 2026-06-08 | Williams Paul Anthony SVP, Products Business | Shares withheld for taxes | −694 | $8.00 | $6K | 162,098 |
| 2026-06-08 | Glessner Coleen EVP, Quality & Ethics, and CPL | Shares withheld for taxes | −2,018 | $8.00 | $16K | 202,201 |
| 2026-06-08 | LINDAHL RICHARD S EVP, Chief Financial Officer | Shares withheld for taxes | −3,964 | $8.00 | $32K | 374,083 |
| 2026-05-01 | Zoon Kathryn C Director | Sale 10b5-1 | −16,145 | $8.36 | $135K | 80,998 |
| 2026-05-01 | Zoon Kathryn C Director | Sale 10b5-1 | −1,057 | $8.97 | $9K | 79,941 |
| 2026-05-01 | DeGolyer Donald W Director | Sale 10b5-1 | −14,527 | $8.36 | $121K | 130,675 |
| 2026-05-01 | DeGolyer Donald W Director | Sale 10b5-1 | −954 | $8.96 | $9K | 129,721 |
| 2026-05-01 | Dayal Sujata Tyagi Director | Sale 10b5-1 | −12,781 | $8.36 | $107K | 101,543 |
| 2026-05-01 | Dayal Sujata Tyagi Director | Sale 10b5-1 | −980 | $8.94 | $9K | 100,563 |
| 2026-04-30 | Zoon Kathryn C Director | Grant or award 10b5-1 | +25,344 | 97,143 | ||
| 2026-04-30 | Zoon Kathryn C Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +11,296 | 11,296 | ||
| 2026-04-30 | DeGolyer Donald W Director | Grant or award 10b5-1 | +25,344 | 145,202 | ||
| 2026-04-30 | DeGolyer Donald W Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +11,296 | 11,296 | ||
| 2026-04-30 | Dayal Sujata Tyagi Director | Grant or award 10b5-1 | +25,344 | 114,324 | ||
| 2026-04-30 | Dayal Sujata Tyagi Director | Grant or award · Stock Option (Right to Buy) 10b5-1 | +11,296 | 11,296 | ||
| 2026-04-30 | Fowler Neal Franklin Director | Grant or award | +25,344 | 160,847 |
Page 1 of 17 · 330 trades